Insomnia Treatment Market 2022 Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast to 2026

Technological innovations have revolutionized lifestyle, communication, business, travel, and healthcare. The healthcare technology industry is continually improving ways to treat neural-related medical conditions, coupled with a significant understanding of subsequent ramifications and consequences.

On the other hand, the pharmaceutical landscape has also transitioned and opened itself to explore novel scientific approaches and innovative technologies within its core therapeutic areas.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/23203

Company Profiles:

Sunovion Pharmaceuticals, Inc.
Natrol, LLC
GlaxoSmithKline Plc.
Sanofi SA
Pfizer Inc.
Boehringer Ingelheim International GmbH
Mallinckrodt
PERNIX Therapeutics
Takeda Pharmaceutical Company Limited
Merck & Co. Inc.
Others.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/23203

New Pharmaceutical Innovations to Address Key Concerns for Sleep Medications

In the 32nd Annual Meeting of the Associated Professional Sleep Societies (SLEEP 2018), Eisai Co., Ltd. and Purdue Pharma L.P showed positive results from clinical trials of lemborexant, which is currently being studied for the potential treatment of multiple sleep disorders, especially insomnia. On examining lemborexant for sleep onset, sleep maintenance, and return to sleep latency, it showed favorable results in terms of postural instability and residual effect compared to placebo and zolpidem (Ambien).

A number of pharmaceutical companies are setting new breakthroughs in the sleep medications segment to cater to specific and unmet needs of insomnia patients. Such innovations are expected to help improve sleep through the night and also allow patients to function appropriately upon awakening, which has been a growing concern among older adults.

Smart Goggles, Wearable Tracking Devices, & Others Are Here to Stay

Multiple companies in the market are working on wearable devices for insomnia treatment, one of which is smart goggles; patients can now be wearing a pair of smart goggles to sleep off.

Recent studies indicate that smart goggles use light and sound stimulations to trigger specific patterns in the brain that would eventually induce sleep. The light emitted by the goggles is of a certain wavelength that stimulates the hypothalamus gland within the brain. This leads to controlled secretion of melatonin, a hormone responsible for sleeping patterns.

Additionally, FDA-approved at-home and wearable tracking devices that monitor brain activity, leg movement, and breathing are becoming more common in the sleep research field. Another 'chemical-free' alternative is telehealth, which involves various ways to communicate with patients about their sleep health. Doctors and researchers are likely to focus on telehealth in near future.

In another research, scientists have discovered that certain cells in the brains of mice, expresses a gene called Lhx6, which promotes sleep. On activation, the Lhx6 gene induces sleep in mice; and awakened mice when deactivated. Moreover, a similar gene is also found in the human hypothalamus gland, and is anticipated to be potentially studied for sleep regulation. It is most likely that the compounds with similar properties as the Lhx6 gene will be incorporated with insomnia drugs, for enhance effectiveness.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/23203

New Drug Formulations to Remain a Key Strategy among Pharmaceutical Industries

A recent study by Persistence Market Research indicates that OTC drugs contribute a maximum revenue share in the global insomnia treatment market, due to increasing preference among insomnia patients. To make insomnia treatment drugs more effective and occupy a greater share of revenue in the global market, the development of new drug formulations is foreseen to remain a key strategy among leading pharmaceutical industries.

Besides expanding geriatric population, some of the most common concerns such as dependency, addiction, and residual symptoms will further compel the requirement of transformed insomnia treatment market over the projection period, 2018-2026. The global market for insomnia treatment is expected to be valued at around US$ 7.5 Bn by 2026 end, witnessing steady expansion at 5.2% CAGR over 2018-2027.

While North America holds the substantial revenue share in the global insomnia treatment market, retail pharmacies are the most preferred to buy insomnia treatment drugs.

Access Related Reports-

Ineffective Esophageal Motility Treatment Market: https://www.persistencemarketresearch.com/market-research/ineffective-esophageal-motility-treatment-market.asp

Oral Macromolecular Formulation Market: https://www.persistencemarketresearch.com/market-research/oral-macromolecule-formulation-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.